Schlusskurs
Andere Börsenplätze
|
||
- USD | 0.00% |
Umsatz 2020 | 23.02 Mio. 20.86 Mio. | Umsatz 2021 | 30.71 Mio. 27.82 Mio. | Marktwert | 28.36 Mio. 25.69 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2020 | 2 Mio. 1.81 Mio. | Nettoergebnis 2021 | 4 Mio. 3.62 Mio. | EV / Sales 2020 | 2.3 x |
Nettoschuld 2020 | 22.85 Mio. 20.7 Mio. | Nettoschuld 2021 | 21.03 Mio. 19.05 Mio. | EV / Sales 2021 | 1.61 x |
KGV 2020 |
10.5
x | KGV 2021 |
5.83
x | Beschäftigte | - |
Rendite 2020 |
2.86% | Rendite 2021 |
3.03% | Streubesitz | 99% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Bassim Nasr
CEO | Chief Executive Officer | - | 01.01.86 |
Maen Hammoudeh
DFI | Director of Finance/CFO | - | - |
Ayman Qaddumi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Hashim Al-Shawa
BRD | Director/Board Member | 48 | - |
Tawfik Habesch
BRD | Director/Board Member | 62 | - |
Bassim Nasr
CEO | Chief Executive Officer | - | 01.01.86 |
% 1. Jan. | Kap. | |
---|---|---|
+33.50% | 701 Mrd. | |
+26.24% | 571 Mrd. | |
+0.78% | 381 Mrd. | |
+20.85% | 334 Mrd. | |
+16.38% | 319 Mrd. | |
+2.62% | 210 Mrd. | |
+1.64% | 210 Mrd. | |
-6.54% | 201 Mrd. | |
-3.51% | 157 Mrd. |
- Börse
- Aktien
- Aktie Dar Al-Shifa Pharmaceuticals Company
- Aktie Pharmacare - Palestine Exchange